Literature DB >> 11873886

Secular trends in antidepressant prescribing in the UK, 1975-1998.

N Middleton1, D Gunnell, E Whitley, D Dorling, S Frankel.   

Abstract

BACKGROUND: We have examined secular trends in age- and sex-specific prescribing of antidepressants to determine whether these mirror changes in other population measures of mental health.
METHOD: An analysis was carried out of age- and sex-specific rates of antidepressant prescribing by a representative sample or panel of UK general practitioners (GPs) in the period 1975-1998.
RESULTS: The number of antidepressant prescriptions issued increased more than twofold in the period 1975-1998 and, in 1998, a total of 23.4 million antidepressant prescriptions were issued by GPs in the United Kingdom. Rates of antidepressant prescribing increased markedly in all age and sex groups with as much as a threefold increase in the older age groups. With the exception of 12-19-year-olds, these increases have been more marked in males, although absolute levels of prescribing are still at least two times higher in females.
CONCLUSIONS: Antidepressant prescribing has increased in all age and sex groups. This indicates either that there have been changes in the presentation, recognition and management of depression in general practice or that the prevalence of depression has increased, or a combination of these two phenomena. The higher prescribing rate in females is in keeping with evidence from psychiatric morbidity surveys suggesting that women experience higher levels of psychiatric morbidity than men. Decreases in the ratio of female to male prescribing, however, support other data indicating that, relative to females, the mental health of young males has declined in recent years. Changes in patterns of help-seeking may also contribute to the observed trends.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11873886     DOI: 10.1093/pubmed/23.4.262

Source DB:  PubMed          Journal:  J Public Health Med        ISSN: 0957-4832


  41 in total

Review 1.  Antidepressants and suicide: what is the balance of benefit and harm.

Authors:  David Gunnell; Deborah Ashby
Journal:  BMJ       Date:  2004-07-03

2.  Suicide rates, life satisfaction and happiness as markers for population mental health.

Authors:  Isabelle Bray; David Gunnell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-03-25       Impact factor: 4.328

3.  Divergent trends in suicide by socio-economic status in Australia.

Authors:  Andrew Page; Stephen Morrell; Richard Taylor; Greg Carter; Michael Dudley
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-09-01       Impact factor: 4.328

4.  Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart.

Authors:  Tzvia Blumstein; Yael Benyamini; Angela Chetrit; Eliyahu H Mizrahi; Liat Lerner-Geva
Journal:  Aging Ment Health       Date:  2012       Impact factor: 3.658

5.  Factors influencing variation in prescribing of antidepressants by general practices in Scotland.

Authors:  Jill Morrison; Mary-Jane Anderson; Matt Sutton; Rosalia Munoz-Arroyo; Sara McDonald; Margaret Maxwell; Andrew Power; Michael Smith; Philip Wilson
Journal:  Br J Gen Pract       Date:  2009-02       Impact factor: 5.386

6.  Improving Access to Psychological Therapies and antidepressant prescribing rates in England: a longitudinal time-series analysis.

Authors:  Vaishnavee Sreeharan; Hugo Madden; John Tayu Lee; Christopher Millett; Azeem Majeed
Journal:  Br J Gen Pract       Date:  2013-09       Impact factor: 5.386

7.  Psychotropic Drug Consumption and Employment Status in Time of Economic Crisis (2007-2011).

Authors:  Cesare Maria Cornaggia; Massimiliano Beghi; Mario Mezzanzanica; Gloria Ronzoni; Giorgio Vittadini; Walter Maffenini
Journal:  Psychiatr Q       Date:  2017-06

8.  Are we going to increase the use of antidepressants up to that of benzodiazepines?

Authors:  Arcangelo Ciuna; Margherita Andretta; Letizia Corbari; Deborah Levi; Mersia Mirandola; Adriano Sorio; Corrado Barbui
Journal:  Eur J Clin Pharmacol       Date:  2004-09-23       Impact factor: 2.953

Review 9.  Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Petros Skapinakis; Eleni Bakola; Georgia Salanti; Glyn Lewis; Athanasios P Kyritsis; Venetsanos Mavreas
Journal:  BMC Neurol       Date:  2010-06-21       Impact factor: 2.474

10.  Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database.

Authors:  Michael Moore; Ho Ming Yuen; Nick Dunn; Mark A Mullee; Joe Maskell; Tony Kendrick
Journal:  BMJ       Date:  2009-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.